OTCPK:STRXF - Post by User
Comment by
SlowLorison Apr 08, 2015 3:25pm
![](https://assets.stockhouse.com/kentico-cms/0341-00/images/Sprite.svg#id_Post_Views_Icon)
54 Views
Post# 23610046
RE:RE:RE:RE:RE:RE:RE:RE:RE:Creeping up ahead of news? I sure hope so lol! eom
RE:RE:RE:RE:RE:RE:RE:RE:RE:Creeping up ahead of news? I sure hope so lol! eomss
I guess you're thinking BlueSpruce project NPV $50m * 8 similar projects (per Hoops in the PR) = $450m ?
I'd use post tax $39m * .2/3 to give a rough idea of NPV15 (I really don't think SXE could raise cash at 10% right now). ie $26m. This is based on 2P, which usually gets risked down in any valuation model. So you could argue the market's valuing SXE on the basis of BlueSpruce only at a fair price.
What are the other projects worth right now, given they don't have the cash at present to do much?Lets say NPV15 at $20m * 8 projects * 10%risk factor = $16m
I think you can argue strongly that SXE is cheap here, and is worth at least double. Even in the mid twenties there is good upside potential for the patient. But I don't think it will be worth $400mil. for a while, and I'm not gonna hold my breath for a dividend.